A WHO guideline panel has updated recommendations for monoclonal antibody treatment in its “living” guide on drugs for COVID-19. The guidelines are published in The BMJ.The panel now recommends a combination of casirivimab and imdevimab (REGEN-COV; Regeneron) for patients with non-severe COVID-19 at high risk for hospitalization and patients with severe or critical COVID-19 who are
ATLANTA — Individuals with a history of e-cigarette use may have increased risk for incident heart failure, regardless of concomitant cigarette, cigar, hookah or smokeless…
WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a…
Use of CAPTURE plus peak expiratory flow resulted in “good” sensitivity and negative predictive value for detecting patients with COPD in need of treatment, according…
Starting exercise training early in a hospitalization for a COPD exacerbation led to improved exercise capacity and physical function at discharge, according to study results…
Black Maternal Health Week is observed April 11 to 17.It is well known that the United States has a maternal health crisis — one that…
In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that although some concerns remain for switching patients between interchangeable biosimilars, data has continued…
An automated algorithm designed to identify rheumatology patients who need to “shield” against COVID-19 demonstrated results that matched the “gold standard” of manual review in…
Ever since my third-year clinical rotations in medical school, I can usually predict what will be written about me in my evaluations before seeing them.…
BALTIMORE — With a global increase in natural disasters, it has become more urgent for nephrology practices to prepare facilities and patients for potential disruptions…
Although the use of computer navigation and robotic assistance yielded longer operative times in total joint arthroplasty, published results showed these methods had no association…
